DePuy Orthopaedics has announced it's voluntary recall of their ASR XL Acetabular System and ASR Hip Resurfacing System used in hip replacement surgery, due to the number of failures in patients within the first five years of implant. These failures can cause serious illnesses and health conditions, and nearly always lead to an unnecessary "revision" surgery to replace the implant. Reports indicate that 12% and 13% of the patients with these ASR hip systems report severe pain, swelling, and loss of mobility, which are signs that the implant could be loosening in the socket, fracturing, or dislocating.
Beginning in September, 2005, an ISMP Medication Safety Alert brought attention to the issue of inaccurate blood glucose readings in some monitoring systems. The FDA had previously issued a warning in July, 2005, and did so again several times over the next four years. They found that these devices, which had become a major tool for hospital personnel and outpatient treatment, could actually be extremely dangerous, if patients and practitioners were not educated in administration methods. They cited a specific example with an elderly patient who was given a high level of insulin after his blood sugar falsely read very high, which resulted in profound hypoglycemia, irreversible neurological damage, and death.